EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of Key Bioactive Compounds of Medicine–Food Homologous Substances and Their Multi-Target Intervention Effects in Osteosarcoma Treatment

Jie Ren, Xue Zhang, Siyu Chen, Ruiming Liu, Pengcheng Yi, Shuang Liu

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27031360 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Jie Ren und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Jiamusi University, Jiamusi 154007, China. Hauptthemen laut MEDLINE: Osteosarcoma, Bone Neoplasms, Antineoplastic Agents. Die Arbeit nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jiamusi University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteosarcoma (OS), a highly aggressive bone malignancy, is hard to treat due to complex molecular mechanisms. This study aimed to identify key bioactive compounds from medicine–food homologous (MFH) substances for OS intervention. We analyzed GEO transcriptomic data to get 317 differentially expressed genes (DEGs), screened bioactive compounds from 106 MFH via dual databases, predicted compound–DEG protein interactions with GraphBAN, and filtered 11 core compounds through drug-likeness/toxicity evaluations. Regulatory networks identified 5 key target genes (SOST, ACACB, TACR1, GRIN2B, MPO), 10 key compounds (e.g., ellagic acid dihydrate) and 8 MFHs (e.g., Daidaihua). Molecular docking/MD confirmed stable complexes. GSEA/GSVA revealed pathway dysregulation (e.g., upregulated WNT signaling), and immune analysis showed altered infiltration of 5 cell subsets. 143B cell experiments and qRT-PCR validated findings. MFH-derived compounds, especially ellagic acid dihydrate, have multi-target anti-OS potential, laying a foundation for novel OS therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaBone NeoplasmsAntineoplastic AgentsHumansMolecular Docking SimulationGene Expression Regulation, NeoplasticCell Line, TumorMolecular Dynamics SimulationGene Regulatory NetworksGene Expression Profiling

Stichwörter der Autor:innen

bioactive compoundsfunctional enrichmentmedicine–food homologous substancemolecular dockingmolecular dynamics simulationosteosarcoma

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • School of Basic Medical Sciences, Jiamusi University, Jiamusi 154007, China.

Förderung

  • Jiamusi University

Zitieren

APA

Ren, J., Zhang, X., Chen, S., Liu, R., Yi, P., & Liu, S. (2026). Identification of Key Bioactive Compounds of Medicine–Food Homologous Substances and Their Multi-Target Intervention Effects in Osteosarcoma Treatment. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27031360

Vancouver

Ren J, Zhang X, Chen S, Liu R, Yi P, Liu S. Identification of Key Bioactive Compounds of Medicine–Food Homologous Substances and Their Multi-Target Intervention Effects in Osteosarcoma Treatment. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27031360

BibTeX
@article{Ren2026,
  author = {Ren, Jie and Zhang, Xue and Chen, Siyu and Liu, Ruiming and Yi, Pengcheng and Liu, Shuang},
  title = {Identification of Key Bioactive Compounds of Medicine–Food Homologous Substances and Their Multi-Target Intervention Effects in Osteosarcoma Treatment},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27031360}
}
Kostenlos starten →